Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1)

Abstract

β-Hydroxyisovalerylshikonin (β-HIVS), which was isolated from the plant, Lithospermum radix, induces apoptosis in various lines of human tumor cells. To identify genes involved in β-HIVS-induced apoptotic process, we performed cDNA array analysis and found that β-HIVS suppresses the expression of the gene for a polo-like kinase 1 (PLK1) that is involved in control of the cell cycle. When U937 and HL60 cells were treated with 10−6M β-HIVS for 0.5 h, both the amount of PLK1 itself and the kinase activity of this enzyme were decreased. By contrast, Bcr–Abl-positive K562 cells were resistant to the induction of apoptosis by β-HIVS and this compound did not suppress the kinase activity of PLK1 in these cells. However, simultaneous treatment of K562 cells with both β-HIVS and STI571, which selectively inhibits the protein tyrosine kinase (PTK) activity of Bcr–Abl, strongly induced apoptosis. Moreover, β-HIVS increased the inhibitory effect of STI571 on PTK activity. Treatment of K562 cells with antisense oligodeoxynucleotides (ODNs) specific for PLK1 sensitized these cells to the β-HIVS-induced fragmentation of DNA. These results suggest that suppression of the activity of PLK1 via inhibition of tyrosine kinase activity by β-HIVS might play a critical role in the induction of apoptosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M and Fukami Y . (1987). J. Biol. Chem., 262, 5592–5595.

  • Barry MA, Behnke CA and Eastman A . (1990). Biochem. Pharmacol., 40, 2353–2362.

  • Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J and Jones RJ . (1995). Blood, 86, 1148–1158.

  • Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME and Huang Y . (1993). Leukemia, 7, 563–568.

  • Brunk CF, Jones KC and James TW . (1979). Anal. Biochem., 92, 497–500.

  • Chalifour LE, Fahmy R, Holder EL, Hutchinson EW, Osterland CK, Schipper HM and Wang E . (1994). Anal. Biochem., 216, 299–304.

  • Cheng L, Hunke L and Hardy CF . (1998). Mol. Cell Biol., 18, 7360–7370.

  • Chomczynski P and Sacchi N . (1987). Anal. Biochem., 162, 156–159.

  • Clay FJ, McEwen SJ, Bertoncello I, Wilks AF and Dunn AR . (1993). Proc. Natl. Acad. Sci. USA, 90, 4882–4886.

  • Cogswell JP, Brown CE, Bisi JE and Neill SD . (2000). Cell Growth Differ., 11, 615–623.

  • Conn CW, Hennigan RF, Dai W, Sanchez Y and Stambrook PJ . (2000). Cancer Res., 60, 6826–6831.

  • Dai W, Li Y, Ouyang B, Pan H, Reissmann P, Li J, Wiest J, Stambrook P, Gluckman JL, Noffsinger A and Bejarano P . (2000). Genes Chromosomes Cancer, 27, 332–336.

  • Datta SR, Brunet A and Greenberg ME . (1999). Genes Dev., 13, 2905–2927.

  • Deininger MW, Goldman JM, Lydon N and Melo JV . (1997). Blood, 90, 3691–3698.

  • Donohue PJ, Alberts GF, Guo Y and Winkles JA . (1995). J. Biol. Chem., 270, 10351–10357.

  • Druker BJ and Tamura S . (1996). Nat. Med., 2, 561–566.

  • Druker BJ, Kantarjian H, Sawyers CL, Resta DJ, Reese SF, Ford JM and Talpaz M . (1999). Blood, 94, 697a.

  • Elez R, Piiper A, Giannini CD, Brendel M and Zeuzem S . (2000). Biochem. Biophys. Res. Commun., 269, 352–356.

  • Evans DL and Dive C . (1993). Cancer Res., 53, 2133–2139.

  • Feinberg AP and Vogelstein B . (1983). Anal. Biochem., 132, 6–13.

  • Feng Y, Hodge DR and Palmieri G . (1999). Biochem. J., 339, 435–442.

  • Friesen C, Herr I, Krammer PH and Debatin KM . (1996). Nat. Med., 2, 574–577.

  • Glover DM, Ohkura H and Tavares A . (1996). J. Cell Biol., 135, 1681–1684.

  • Glover DM, Hagan IM and Tavares AA . (1998). Genes Dev., 12, 3777–3787.

  • Gross A, McDonnell JM and Korsmeyer SJ . (1999). Genes Dev., 13, 1899–1911.

  • Hamanaka R, Smith MR, O'Connor PM, Maloid S, Mihalic K, Spivak JL, Longo DL and Ferris DK . (1995). J. Biol. Chem., 270, 21086–21091.

  • Hamdane M, David-Cordonnier MH and D'Halluin JC . (1997). Oncogene, 15, 2267–2275.

  • Hashimoto S, Xu M, Masuda Y, Aiuchi T, Nakajo S, Cao J, Miyakoshi M, Ida Y and Nakaya K . (1999). J. Biochem. (Tokyo), 125, 17–23.

  • Hashimoto S, Xu M, Masuda Y, Aiuchi T, Nakajo S, Uehara Y, Shibuya M, Yamori T and Nakaya K . (2002). Jpn. J. Cancer Res., 93, 944–951.

  • Hurle JM, Lafarga M and Hinchliffe JR . (1981). Exp. Cell Res., 133, 465–470.

  • Kaufmann SH . (1989). Cancer Res., 49, 5870–5878.

  • Kerr JF, Wyllie AH and Currie AR . (1972). Br. J. Cancer, 26, 239–257.

  • Kotani S, Tugendreich S, Fujii M, Jorgensen PM, Watanabe N, Hoog C, Hieter P and Todokoro K . (1998). Mol. Cell, 1, 371–380.

  • Lane HA and Nigg EA . (1996). J. Cell Biol., 135, 1701–1713.

  • Laurent-Crawford AG, Krust B, Riviere Y, Desgranges C, Muller S, Kieny MP, Dauguet C and Hovanessian AG . (1991). Virology, 185, 829–839.

  • Lehrach H, Diamond D, Wozney JM and Boedtker H . (1977). Biochemistry, 16, 4743–4751.

  • Li B, Ouyang B, Pan H, Reissmann PT, Slamon DJ, Arceci R, Lu L and Dai W . (1996). J. Biol. Chem., 271, 19402–19408.

  • Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K . (1995) Leuk. Res., 19, 549–556.

  • Masuda Y, Yoda M, Ohizumi H, Aiuchi T, Watabe M, Nakajo S and Nakaya K . (1997). Int. J. Cancer, 71, 691–697.

  • McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR and Cotter TG . (1994). Blood, 83, 1179–1187.

  • Nigg EA . (1998). Curr. Opin. Cell Biol., 10, 776–783.

  • Ohizumi H, Masuda Y, Nakajo S, Sakai I, Ohsawa S and Nakaya K . (1995). J. Biochem. (Tokyo), 117, 11–13.

  • Perkins C, Kim CN, Fang G and Bhalla KN . (1998). Cancer Res., 58, 4561–4566.

  • Qian YW, Erikson E, Li C and Maller JL . (1998a). Mol. Cell Biol., 18, 4262–4271.

  • Qian YW, Erikson E and Maller JL . (1998b). Science, 282, 1701–1704.

  • Reed JC . (1999). J. Clin. Oncol., 17, 2941–2953.

  • Sakai I, Tanaka T, Osawa S, Hashimoto S and Nakaya K . (1993). Biochem. Biophys. Res. Commun., 191, 873–879.

  • Sakai I, Hashimoto S, Yoda M, Hida T, Ohsawa S, Nakajo S and Nakaya K . (1994). Biochem. Biophys. Res. Commun., 205, 1305–1310.

  • Schena M, Shalon D, Davis RW and Brown PO . (1995). Science, 270, 467–470.

  • Simmons DL, Neel BG, Stevens R, Evett G and Erikson RL . (1992). Mol. Cell Biol., 12, 4164–4169.

  • Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN and Calabretta B . (1997). EMBO J., 16, 6151–6161.

  • Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL and Ferris DK . (1997). Biochem. Biophys. Res. Commun., 234, 397–405.

  • Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA and Medema RH . (2000). Nat. Cell Biol., 2, 672–676.

  • Sunkel CE and Glover DM . (1988). J. Cell Sci., 89, 25–38.

  • Thiesing JT, Ohno-Jones S, Kolibaba KS and Druker BJ . (2000). Blood, 96, 3195–3199.

  • Thomas PS . (1980). Proc. Natl. Acad. Sci. USA, 77, 5201–5205.

  • Ucker DS . (1987). Nature, 327, 62–64.

  • Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K . (1996). J. Biol. Chem., 271, 14067–14072.

  • Watabe M, Kawazoe N, Masuda Y, Nakajo S and Nakaya K . (1997). Cancer Res., 57, 3097–3100.

  • Wyllie AH . (1980). Nature, 284, 555–556.

  • Wyllie AH, Morris RG, Smith AL and Dunlop D . (1984). J. Pathol., 142, 67–77.

  • Zou H, Henzel WJ, Liu X, Lutschg A, Wang X . (1997). Cell, 90, 405–413.

Download references

Acknowledgements

This work was supported in part by Grants-in-Aid from the Ministry of Education, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuyasu Nakaya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Masuda, Y., Nishida, A., Hori, K. et al. β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1). Oncogene 22, 1012–1023 (2003). https://doi.org/10.1038/sj.onc.1206200

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1206200

Keywords

This article is cited by

Search

Quick links